Aurora Cannabis said that its dedicated distribution center located in Brampton, Ontario, has received European Union Good Manufacturing Practice (EU-GMP) certification, increasing the company's international export capabilities. The distribution center joins Aurora's group of manufacturing facilities in Canada and Europe certified against EU standards.
"Securing EU-GMP certification at manufacturing and distribution facilities within our network is an important validation of our differentiated approach to operating as a global medical cannabis company," said Jill Lau, Vice President of Canadian Operations at Aurora. "By adding certification for our distribution center, we are now uniquely positioned to ensure patients worldwide have consistent access to superior quality medical cannabis from the largest Canadian exporter."
EU-GMP certification is granted to companies whose production facilities meet the requirements under the EudraLex "Rules Governing Medicinal Products in the European Union," and that can demonstrate a high degree of quality and consistency in their manufacturing procedures, a requirement for the export of medical cannabis products into Europe. EU-GMP certification of the company's distribution centre allows it to serve as a centralized site for more optimized and efficient receipt, storage and distribution of materials and finished products internationally.
With operations across Canada and in Europe, Aurora remains at the forefront of the global medical cannabis industry. By continuously investing in operational capabilities, regulatory excellence, and a science-led approach, Aurora is best positioned to deliver high-quality medical cannabis that meets and exceeds the highest international standards.
